These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27476468)

  • 1. Diagnostic value of microRNAs as biomarkers for cholangiocarcinoma.
    Liang Z; Liu X; Zhang Q; Wang C; Zhao Y
    Dig Liver Dis; 2016 Oct; 48(10):1227-32. PubMed ID: 27476468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
    Liang B; Zhong L; He Q; Wang S; Pan Z; Wang T; Zhao Y
    Med Sci Monit; 2015 Nov; 21():3555-63. PubMed ID: 26576628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of microRNAs as biomarkers for cholangiocarcinoma detection: A diagnostic meta-analysis.
    Zhou J; Liu Z; Yang S; Li X
    Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):156-162. PubMed ID: 27939910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma.
    Tang Z; Yang Y; Wang X; Meng W; Li X
    BMJ Open; 2019 Jan; 9(1):e021693. PubMed ID: 30700476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z; Ma J
    Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma.
    Wang LJ; Zhang KL; Zhang N; Ma XW; Yan SW; Cao DH; Shi SJ
    Oncotarget; 2015 Jul; 6(21):18631-40. PubMed ID: 26087181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic performance of serum MUC5AC for cholangiocarcinoma: A systematic review and meta-analysis.
    Xuan J; Li J; Zhou Z; Zhou R; Xu H; Wen W
    Medicine (Baltimore); 2016 Jun; 95(24):e3513. PubMed ID: 27310944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNA-21 as a prognostic, biological marker in cholangiocarcinoma.
    Liu CH; Huang Q; Jin ZY; Xie F; Zhu CL; Liu Z; Wang C
    J Cancer Res Ther; 2018 Jan; 14(1):220-225. PubMed ID: 29516989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma.
    Jiang Y; Zheng X; Jiao D; Chen P; Xu Y; Wei H; Qian Y
    EBioMedicine; 2019 Feb; 40():422-431. PubMed ID: 30638862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma.
    Puik JR; Meijer LL; Le Large TY; Prado MM; Frampton AE; Kazemier G; Giovannetti E
    Pharmacogenomics; 2017 Sep; 18(14):1343-1358. PubMed ID: 28832247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
    Likhitrattanapisal S; Tipanee J; Janvilisri T
    Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic efficacy of CYFRA21-1 on intrahepatic cholangiocarcinoma: A meta-analysis.
    Guowei H; Yuan L; Ma L; Zhongyang L; Zhixing S; Lin L; Minqi L
    Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):266-272. PubMed ID: 30503663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator.
    Silakit R; Loilome W; Yongvanit P; Chusorn P; Techasen A; Boonmars T; Khuntikeo N; Chamadol N; Pairojkul C; Namwat N
    J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):864-72. PubMed ID: 25131257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of long non-coding RNAs in cholangiocarcinoma: A systematic review and meta-analysis.
    Shobeiri P; Arabzadeh Bahri R; Khadembashiri MM; Khadembashiri MA; Maleki S; Eslami M; Khalili Dehkordi M; Behnoush AH; Rezaei N
    Cancer Rep (Hoboken); 2024 Mar; 7(3):e2029. PubMed ID: 38517409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases.
    Wasenang W; Chaiyarit P; Proungvitaya S; Limpaiboon T
    Clin Epigenetics; 2019 Mar; 11(1):39. PubMed ID: 30832707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
    Chen L; Cui Z; Liu Y; Bai Y; Lan F
    Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
    Zhang L; Cao D; Tang L; Sun C; Hu Y
    Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma.
    Cheng Q; Feng F; Zhu L; Zheng Y; Luo X; Liu C; Yi B; Jiang X
    Sci Rep; 2015 Nov; 5():16103. PubMed ID: 26534789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid/ Hyaluronidase as biomarkers for bladder cancer: a diagnostic meta-analysis.
    Liang Z; Zhang Q; Wang C; Shi F; Cao H; Yu Y; Zhang M; Liu X
    Neoplasma; 2017; 64(6):901-908. PubMed ID: 28895415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Xu F; Xu L; Wang M; An G; Feng G
    Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.